GlassScriptPhysician profile
Ramona Raj
NPI 1952504524
$3,178.46
in general payments reported to CMS, 2019-2025
31 companies · $624 in 2025
The $624 reported for 2025 was more than what a typical Endocrinology, Diabetes & Metabolism provider received nationally (typical 2025 total: $506).
See the full distribution for Endocrinology, Diabetes & Metabolism
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $548 · 2020: $97.95 · 2021: $145 · 2022: $503 · 2023: $620 · 2024: $641 · 2025: $624.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,885.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,885.34 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $393.66 | 2019-2025 | Ozempic, Rybelsus |
| Lilly USA, LLC | $393.07 | 2019-2025 | Mounjaro, Jardiance, Zepbound |
| Boehringer Ingelheim Pharmaceuticals, INC. | $318.88 | 2019-2025 | Jardiance |
| Insulet Corporation | $210.56 | 2019-2025 | Omnipod |
| Abbvie INC. | $205.31 | 2019-2025 | |
| Dexcom, INC. | $187.92 | 2022-2025 | Dexcom G6 Transmitter |
| Medtronic, INC. | $185.47 | 2022-2025 | Minimed 780g, Inpen Smart Insulin Delivery System |
| Amneal Pharmaceuticals LLC | $170.58 | 2019-2025 | Unithroid |
| Mannkind Corporation | $154.35 | 2019-2024 | Afrezza |
| Xeris Pharmaceuticals, INC. | $135.92 | 2021-2025 | Gvoke Hypopen |
| Astrazeneca Pharmaceuticals LP | $110.69 | 2019-2022 | |
| Amgen INC. | $83.95 | 2019-2025 | Tepezza, Evenity |
| Cleerly, INC. | $77.81 | 2025 | Cleerly Ischemia, Cleerly Labs |
| Sanofi-Aventis U.S. LLC | $63.78 | 2021-2025 | |
| Horizon Therapeutics Plc | $54.56 | 2022-2023 | Tepezza |
Show all 31 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tandem Diabetes Care, INC. | $49.54 | 2025 | T:Slim X2 Insulin Pump With Control-Iq |
| Janssen Pharmaceuticals, INC | $40.84 | 2019 | |
| Medtronic Minimed, INC. | $37.20 | 2019-2020 | |
| Ibsa Pharma INC. | $31.27 | 2019-2023 | Tirosint, Licart |
| Corcept Therapeutics | $31.25 | 2024 | Korlym |
| Abbott Laboratories | $31.24 | 2023-2024 | Freestyle Libre 3 |
| Beta Bionics, INC. | $29.44 | 2024-2025 | Ilet Bionic Pancreas, Ilet Insulin Infusion Kit Inset, Ilet Insulin Infusion Kit Contact Detach |
| Sequel Med Tech, LLC | $28.05 | 2025 | Twiist |
| Ascensia Diabetes Care US INC. | $27.13 | 2024 | |
| Recordati_rare_diseases_inc. | $22.62 | 2024 | Signifor Lar, Isturisa |
| Radius Health, INC. | $21.54 | 2024 | Tymlos |
| Tolmar, INC. | $20.21 | 2023 | |
| Alexion Pharmaceuticals, INC. | $20.03 | 2021 | |
| Bigfoot Biomedical INC | $16.43 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $13.89 | 2022 | |
| Amarin Pharma, INC. | $11.27 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ramona Raj listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.